Generics - Sanofi, Pharmaceutical

Filter

Current filters:

SanofiPharmaceutical

Popular Filters

US FDA warns pregnant women to not use valproate migraine prevention medicines

07-05-2013

The US Food and Drug Administration is alerting health care providers and patients that medications including…

Abbott LaboratoriesGenericsNeurologicalNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationSanofivalproate Sodium Injection

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer

28-04-2013

The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Sanofi yet another to be hit by generic competition

26-10-2012

Continuing the trend reported by other drug majors reporting third-quarter 2012 financial results so…

FinancialGenericsPharmaceuticalSanofi

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses

17-05-2012

GenericsWeb, a patent analysis and search company, recently published an article based on its proprietary…

Bristol-Myers SquibbCardio-vascularClopidogrelGenericsPatentsPharmaceuticalPlavixSanofi

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

Sanofi considers expanding in Ukraine pharma market

24-02-2012

French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Back to top